Satiating Diet vs. Restrictive Intervention for Obesity
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores different approaches to weight loss and maintenance for individuals with obesity. It compares a non-restrictive diet designed to promote fullness with a traditional calorie-cutting diet. The goal is to determine which method better controls appetite and supports long-term weight maintenance. Participants should have a BMI (body mass index) of 30 or more, a waist circumference over 102 cm for men or 88 cm for women, and should not be taking medications that affect weight. The trial lasts 18 months and includes regular follow-ups with a dietitian. As an unphased trial, this study offers a unique opportunity to contribute to innovative research that could enhance weight management strategies for many.
Will I have to stop taking my current medications?
If you are taking medications that could affect your appetite or body weight, such as thyroid replacement therapy, sulfonylureas, or glucocorticoids, you will not be eligible to participate in this trial.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that both the non-restrictive satiating diet and the conventional restrictive diet are generally well-tolerated by participants. Studies have found that the non-restrictive satiating diet helps people adhere to the plan and reduces body fat without causing major health problems. Participants reported feeling fuller for longer, which helped them avoid overeating.
In contrast, the conventional restrictive diet effectively aids weight loss. However, some people find it difficult to maintain over time.
Current research considers both diets safe. Studies have not reported major health issues for either diet. Overall, these diets appear safe for people with obesity, although individual experiences may vary.12345Why are researchers excited about this trial?
Researchers are excited about the trial comparing a satiating diet against restrictive interventions for obesity because it offers a fresh approach to weight management. Unlike traditional calorie-restrictive diets, which often focus on reducing calorie intake by a set amount, the non-restrictive satiating intervention emphasizes the consumption of meals that are not only filling but also low in energy density and glycemic index. This approach incorporates foods high in protein, healthy fats, and essential nutrients, leveraging the natural satiating properties of ingredients like capsaicin found in spices. By potentially enhancing satiety and maintaining nutritional balance without strict calorie limits, this method might offer a more sustainable and enjoyable path to weight loss.
What evidence suggests that this trial's treatments could be effective for obesity?
This trial will compare a conventional restrictive intervention with a non-restrictive satiating intervention for obesity. Research has shown that traditional diets, which involve cutting calories, can lead to moderate weight loss. Studies have found that these diets can help people lose about 5% of their body weight, and a 15-week program might result in losing around 11 kg, with many maintaining the weight loss. Participants in this trial may receive this type of intervention.
In contrast, the non-restrictive satiating intervention, another option in this trial, focuses on filling meals that are low in calories but rich in nutrients like protein and healthy fats. This diet has shown promise because it helps people adhere to it and reduces body fat. It works by making people feel fuller and more satisfied, aiding weight control over time. Both diet strategies are effective, but they manage weight in different ways.678910Are You a Good Fit for This Trial?
This trial is for men and women aged 18-50 with obesity, defined by a waist circumference over 102 cm for men or over 88 cm for women, and a BMI between 30 and <40. Participants should not be on medications affecting weight or appetite, have chronic diseases, use excessive alcohol or caffeine, or be pregnant. They also shouldn't engage in high physical activity.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Weight Loss Phase
Participants undergo a 6-month weight loss intervention with different strategies: non-restrictive satiating intervention, conventional restrictive intervention, or minimal healthy guidelines.
Maintenance Phase
Participants continue with a 12-month weight maintenance intervention, either continuing the non-restrictive satiating intervention or switching from a restrictive intervention.
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Control group
- Conventional restrictive intervention + non-restrictive satiating intervention
- Non-restrictive satiating intervention
Find a Clinic Near You
Who Is Running the Clinical Trial?
Laval University
Lead Sponsor
University of Ottawa
Collaborator